SM
OGEN icon

Sabby Management’s Oragenics OGEN Stock Holding History

Sabby Management’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-61,740
Closed -$48.4K – 39
2025
Q4 		$48.4K Buy
61,740
+2,787
+5% +$3.02K 0.07% 31
2025
Q3 		$77.2K Buy
+58,953
New +$74.5K 0.09% 31
2020
Q1 		– Sell
-195
Closed -$184K – 99
2019
Q4 		$184K Sell
195
-149
-43% -$133K 0.05% 51
2019
Q3 		$334K Sell
344
-356
-51% -$297K 0.18% 56
2019
Q2 		$617K Buy
700
+416
+146% +$382K 0.78% 26
2019
Q1 		$299K Buy
+284
New +$447K 0.14% 44

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
AAS
Ameritas Advisory Services Lincoln, Nebraska $4.96B AUM 27.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SJIM
St. Johns Investment Management Jacksonville, Florida $264M AUM 29.48% 1-Year Est. Return

Sabby Management's OGEN Position: Q1 2026 in Review

Sabby Management sold out of Oragenics (OGEN) in Q1 2026, closing a stake of 61,740 shares — an estimated $48.4K sold.

Sabby Management first reported a position in OGEN in Q1 2019 and held it in 6 quarters. The position peaked at $617K in Q2 2019. 20 funds tracked by Wall St. Rank hold OGEN as of Q1 2026.

  • Sabby Management reported no remaining Oragenics position as of Q1 2026 after selling out during the quarter.
  • Sabby Management sold 61,740 Oragenics shares in Q1 2026, an estimated $48.4K.
  • Sabby Management first reported a position in Oragenics in Q1 2019 and held it in 6 quarters.
  • Sabby Management's Oragenics position peaked at $617K in Q2 2019.
  • 20 funds tracked by Wall St. Rank held Oragenics as of Q1 2026.

Based on Sabby Management's 13F filing for Q1 2026, filed 15 May 2026.